VanEck Associates’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Sell
2,552
-359
-12% -$45.4K ﹤0.01% 1260
2026
Q1
$313K Buy
2,911
+502
+21% +$56.5K ﹤0.01% 1228
2025
Q4
$272K Buy
2,409
+671
+39% +$64.1K ﹤0.01% 1257
2025
Q3
$142K Buy
1,738
+339
+24% +$31.1K ﹤0.01% 1304
2025
Q2
$145K Sell
1,399
-10
-0.7% -$938 ﹤0.01% 1279
2025
Q1
$139K Buy
1,409
+275
+24% +$36.7K ﹤0.01% 1255
2024
Q4
$170K Sell
1,134
-81
-7% -$11.2K ﹤0.01% 1243
2024
Q3
$158K Sell
1,215
-242
-17% -$30.1K ﹤0.01% 1215
2024
Q2
$172K Sell
1,457
-381
-21% -$40.5K ﹤0.01% 1200
2024
Q1
$173K Sell
1,838
-123
-6% -$11K ﹤0.01% 1192
2023
Q4
$156K Buy
1,961
+27
+1% +$1.84K ﹤0.01% 1192
2023
Q3
$146K Buy
1,934
+75
+4% +$5.6K ﹤0.01% 1182
2023
Q2
$132K Sell
1,859
-656
-26% -$37.7K ﹤0.01% 1209
2023
Q1
$126K Sell
2,515
-60
-2% -$2.91K ﹤0.01% 1221
2022
Q4
$112K Buy
+2,575
New +$127K ﹤0.01% 1229

Other funds holding GKOS

VanEck Associates's GKOS Position: Q2 2026 in Review

VanEck Associates reduced its Glaukos (GKOS) stake by 12% in Q2 2026, selling an estimated $45.4K and leaving 2,552 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #1260.

VanEck Associates first reported a position in GKOS in Q4 2022 and has held it in 15 quarters since. 365 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • VanEck Associates held 2,552 shares of Glaukos worth $357K as of Q2 2026.
  • VanEck Associates sold 359 Glaukos shares in Q2 2026, an estimated $45.4K.
  • Glaukos made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1260 holding.
  • VanEck Associates first reported a position in Glaukos in Q4 2022 and has held it in 15 quarters since.
  • 365 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.